Stockreport

Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistine [Yahoo! Finance]

Altamira Therapeutics Ltd. - Common Shares  (CYTO) 
PDF company dedicated to developing therapeutics that address important unmet medical needs, today announced that it has received an “Intention to Grant” notice from the Eur [Read more]